NDC 11523-7157 – Claritin Reditabs

Loratadine 10 mg/1 · Tablet, Orally Disintegrating · Oral

Human Otc Drug

Product NDC11523-7157

Product details

Brand name
Claritin Reditabs
Generic name
Loratadine
Labeler
Bayer Healthcare LLC.
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
NDA · NDA020704
Marketed since
November 27, 2002
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Claritin →

Package NDC codes (6)

Package NDCDescriptionSince
11523-7157-21 BLISTER PACK in 1 CARTON (11523-7157-2) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKNov 27, 2002
11523-7157-33 BLISTER PACK in 1 CARTON (11523-7157-3) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKNov 27, 2002
11523-7157-42 BLISTER PACK in 1 CARTON (11523-7157-4) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKNov 27, 2002
11523-7157-74 BLISTER PACK in 1 CARTON (11523-7157-7) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKNov 27, 2002
11523-7157-85 BLISTER PACK in 1 CARTON (11523-7157-8) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKNov 27, 2002
11523-7157-97 BLISTER PACK in 1 CARTON (11523-7157-9) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKNov 27, 2002

Other Claritin products